Compare FNRN & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNRN | IPSC |
|---|---|---|
| Founded | 1910 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.1M | 306.0M |
| IPO Year | 2000 | 2021 |
| Metric | FNRN | IPSC |
|---|---|---|
| Price | $17.73 | $1.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.75 |
| AVG Volume (30 Days) | 87.4K | ★ 440.0K |
| Earning Date | 07-29-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.42 | ★ 91.30 |
| EPS | ★ 0.64 | N/A |
| Revenue | N/A | ★ $109,164,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $27.56 | ★ N/A |
| Revenue Growth | N/A | ★ 1556.76 |
| 52 Week Low | $15.93 | $0.44 |
| 52 Week High | $19.25 | $2.97 |
| Indicator | FNRN | IPSC |
|---|---|---|
| Relative Strength Index (RSI) | 62.52 | 26.31 |
| Support Level | $17.52 | $0.90 |
| Resistance Level | $17.88 | $2.59 |
| Average True Range (ATR) | 0.35 | 0.10 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 80.51 | 4.21 |
First Northern Community Bancorp is a bank holding company for a community bank, First Northern Bank of Dixon. It conducts general banking activities, including collecting deposits and originating loans, and serves Solano, Yolo, Sacramento, Placer, El Dorado, and Contra Costa Counties. It offers a broad range of alternative investment products and services, equipment leasing, credit cards, merchant card processing, payroll services, and limited international banking services. The bank generates the majority of its revenue by providing various products and services to small and medium-sized businesses and individuals. including accepting demand, interest bearing transaction, savings, and time deposits, and making commercial, consumer, and real estate-related loans.
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.